Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Blue Owl Credit Income Corp. is a non-diversified, closed-end management investment company that has elected to be regulated as a business development company (BDC). The company's primary investment objective is to generate current income and, to a lesser extent, capital appreciation by targeting direct lending opportunities in U.S. middle-market companies. It primarily invests in senior secured loans, including first lien, second lien, and unitranche loans, across a variety of industries including healthcare, software, and financial services. The fund is externally managed by Blue Owl Capital, a leading alternative asset manager specializing in direct lending and specialized capital solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Blue Owl Credit Income Corp..